REQUEST A DEMO
Total
USD $0.00
Search more companies

Polifarma Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Polifarma Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Polifarma Ilac A.S. is an enterprise based in Turkiye. Its main office is in Istanbul. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on March 27, 1986. Polifarma Ilac A.S. currently employs 1,733 (2025) people. The latest financial highlights indicate a net sales revenue drop of 3.54% in 2024. Its’ total assets recorded a growth of 11.88%. The net profit margin of Polifarma Ilac A.S. decreased by 11.74% in 2024.

Headquarters
Capital Tower Sitesi D:6 No:9 Halkali Merkez Mahallesi Basin Ekspres Caddesi Kucukcekmece
Istanbul; Marmara; Postal Code: 34303

Contact Details: Purchase the Polifarma Ilac A.S. report to view the information.

Website: http://www.polifarma.com.tr

Basic Information
Total Employees:
Purchase the Polifarma Ilac A.S. report to view the information.
Financial Auditors:
Purchase the Polifarma Ilac A.S. report to view the information.
Incorporation Date:
March 27, 1986
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Polifarma Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
-3.54%
Total operating revenue
-3.54%
Operating profit (EBIT)
-28.58%
Net Profit (Loss) for the Period
-52%
Total assets
11.88%
Total equity
13.06%
Operating Profit Margin (ROS)
-10.59%
Net Profit Margin
-11.74%
Return on Equity (ROE)
-20.92%
Debt to Equity Ratio
7.58%
Quick Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?